ES398358A1 - Procedimiento de obtencion de inhibidores para hidrolasas de glicosidos. - Google Patents

Procedimiento de obtencion de inhibidores para hidrolasas de glicosidos.

Info

Publication number
ES398358A1
ES398358A1 ES398358A ES398358A ES398358A1 ES 398358 A1 ES398358 A1 ES 398358A1 ES 398358 A ES398358 A ES 398358A ES 398358 A ES398358 A ES 398358A ES 398358 A1 ES398358 A1 ES 398358A1
Authority
ES
Spain
Prior art keywords
culture
inhibitors
glycoside
mycelium
separate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES398358A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES398358A1 publication Critical patent/ES398358A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/896—Streptomyces fradiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/907—Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
ES398358A 1970-12-28 1971-12-27 Procedimiento de obtencion de inhibidores para hidrolasas de glicosidos. Expired ES398358A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2064092A DE2064092C2 (de) 1970-12-28 1970-12-28 Inhibitoren für Glykosidhydrolasen aus Actinomyceten

Publications (1)

Publication Number Publication Date
ES398358A1 true ES398358A1 (es) 1974-09-01

Family

ID=5792372

Family Applications (1)

Application Number Title Priority Date Filing Date
ES398358A Expired ES398358A1 (es) 1970-12-28 1971-12-27 Procedimiento de obtencion de inhibidores para hidrolasas de glicosidos.

Country Status (28)

Country Link
US (1) US3876766A (pl)
JP (3) JPS5734996B1 (pl)
KR (1) KR780000248B1 (pl)
AR (1) AR193370A1 (pl)
AT (1) AT330122B (pl)
AU (1) AU461521B2 (pl)
BE (1) BE777387A (pl)
BG (3) BG25654A3 (pl)
CA (1) CA979833A (pl)
CH (1) CH594051A5 (pl)
CS (1) CS167961B2 (pl)
DD (1) DD99395A5 (pl)
DE (1) DE2064092C2 (pl)
DK (1) DK139533C (pl)
ES (1) ES398358A1 (pl)
FI (1) FI49774C (pl)
FR (1) FR2120073B1 (pl)
GB (1) GB1374751A (pl)
IE (1) IE35920B1 (pl)
IL (1) IL38441A (pl)
LU (1) LU64319A1 (pl)
NL (1) NL175199C (pl)
NO (1) NO135873C (pl)
PL (1) PL82900B1 (pl)
RO (3) RO63064A (pl)
SE (1) SE398357B (pl)
SU (1) SU454750A3 (pl)
ZA (1) ZA718677B (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2209834C3 (de) * 1972-03-01 1978-04-20 Bayer Ag, 5090 Leverkusen Herstellung von Saccharase-Inhibitoren
DE2209833C3 (de) * 1972-03-01 1978-06-01 Bayer Ag, 5090 Leverkusen Herstellung eines Amylaseinhibitors
DE2209832C3 (de) * 1972-03-01 1979-03-29 Bayer Ag, 5090 Leverkusen Herstellung von Saccharaseinhibitoren
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
FR2338707A1 (fr) * 1976-01-22 1977-08-19 Rhone Poulenc Ind Nouvel inhibiteur de glyco-hydrolases et sa preparation par culture d'un streptomyces
DE2658563A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Inhibitoren fuer glykosid-hydrolasen aus bacillen
DE2701890C2 (de) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung
DE2719912C3 (de) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
GB2016497A (en) * 1978-02-10 1979-09-26 Taisho Pharmaceutical Co Ltd Microbiological production of amylase inhibitor
CA1121290A (en) * 1978-02-14 1982-04-06 Yasuji Suhara Amino sugar derivatives
JPS62160696A (ja) * 1986-01-07 1987-07-16 シャープ株式会社 電子式自動点滅器
ATE89563T1 (de) * 1986-08-13 1993-06-15 Hoechst Ag Oxiran-pseudooligosaccharide, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
US5464828A (en) * 1988-03-02 1995-11-07 Chugai Pharmaceutical Co., Ltd. Aqueous suspension of sucralfate
DE19507214A1 (de) * 1995-03-02 1996-10-31 Bayer Ag Acarbose-Biosynthesegene aus Actinoplanes sp., Verfahren zu ihrer Isolierung sowie ihre Verwendung
EP0796915A3 (de) * 1996-03-22 1999-04-14 Bayer Ag Verfahren zur Herstellung sowie zur Verwendung von Acarviosyl-Transferase bei der Umwandlung von Acarbose-Homologen in Acarbose, zur Herstellung von Acarbose-Homologen
DE19637591A1 (de) * 1996-09-13 1998-03-19 Bayer Ag Osmokontrolliertes Fermentationsverfahren zur Herstellung von Acarbose
JP3992497B2 (ja) 1999-10-28 2007-10-17 チョン・クン・ダン・ファーマシューティカル・コーポレーション 高純度アカルボース製造方法
HRP20010792A2 (en) 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
US9217154B2 (en) 2011-12-08 2015-12-22 Bayer Intellectual Property Gmbh Actinomycete integrative and conjugative element from Actinoplanes sp. SE50/110 as plasmid for genetic transformation of related Actinobacteria
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
CN114555811A (zh) 2019-10-16 2022-05-27 拜耳公司 用于改善阿卡波糖形成的方法
US11802838B2 (en) 2020-03-23 2023-10-31 Bay State Milling Company Rapid high amylose wheat seed purity test

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127315A (en) * 1964-03-31 Hypocholesterolemic agent m-

Also Published As

Publication number Publication date
ATA1111571A (de) 1975-09-15
FR2120073B1 (pl) 1975-12-26
CS167961B2 (pl) 1976-05-28
NO135873B (pl) 1977-03-07
DK139533C (da) 1979-08-20
NL7117893A (pl) 1972-06-30
SE398357B (sv) 1977-12-19
IL38441A (en) 1974-10-22
PL82900B1 (pl) 1975-10-31
FI49774B (pl) 1975-06-30
AR193370A1 (es) 1973-04-23
AU3721471A (en) 1973-09-27
NL175199C (nl) 1984-10-01
BG26002A4 (pl) 1979-01-12
US3876766A (en) 1975-04-08
RO63065A (fr) 1979-02-15
IL38441A0 (en) 1972-02-29
AU461521B2 (en) 1975-05-29
CA979833A (en) 1975-12-16
RO61400A (pl) 1977-01-15
JPS57150395A (en) 1982-09-17
LU64319A1 (pl) 1972-06-13
ZA718677B (en) 1972-09-27
DK139533B (da) 1979-03-05
BG26003A4 (pl) 1979-01-12
KR780000248B1 (en) 1978-07-06
GB1374751A (en) 1974-11-20
AT330122B (de) 1976-06-10
NL175199B (nl) 1984-05-01
NO135873C (pl) 1977-06-15
DE2064092A1 (de) 1972-07-20
JPS6234396B2 (pl) 1987-07-27
IE35920B1 (en) 1976-06-23
SU454750A3 (ru) 1974-12-25
RO63064A (fr) 1978-06-15
CH594051A5 (pl) 1977-12-30
JPS6216638B2 (pl) 1987-04-14
DE2064092C2 (de) 1983-06-01
FI49774C (fi) 1975-10-10
BE777387A (fr) 1972-06-28
DD99395A5 (pl) 1973-08-05
IE35920L (en) 1972-06-28
BG25654A3 (pl) 1978-11-10
JPS5734996B1 (pl) 1982-07-26
FR2120073A1 (pl) 1972-08-11
JPS57150396A (en) 1982-09-17

Similar Documents

Publication Publication Date Title
ES398358A1 (es) Procedimiento de obtencion de inhibidores para hidrolasas de glicosidos.
ES380126A1 (es) Un procedimiento para la preparacion de un producto enzima-tico que contiene una alfa-amilasa.
SE7704301L (sv) Antibiotika
SE8105079L (sv) Antibiotikum bmg162-af2
GB1404516A (en) Stabilization of microorganism cells lytic enzyme
ES380545A1 (es) Proceso de produccion de una nueva sustancia biologicamenteactiva, la pepstatina.
GB1133579A (en) Process for preparing proteases and enzymatic composition prepared thereby
GB1240620A (en) Process for the production of a dextran-degrading enzyme
ES394210A1 (es) Un procedimiento para la preparacion de una nueva sustanciaantibiotica de amplio espectro antimicrobiano.
ES302471A1 (es) Un procedimiento para producir d-ribosa-5-fosfato por fermentacion.
ES309611A1 (es) Procedimiento para la preparacion de lincomicina b.
ES282246A2 (es) Procedimiento para evitar el enfieltramiento de la lana
ES323766A1 (es) Un procedimiento para la preparacion de amilasa estable y activa en medio acido.
ES387479A1 (es) Un procedimiento para producir una sustancia antibiotica- mente activa.
GB1196835A (en) An improved Fermentation process for the production of Lysostaphin
ES272921A1 (es) Procedimiento para la potenciaciën de la actividad de los productos queratoliticos enzimaticos
ES309868A1 (es) Un procedimiento para preparar oxitetraciclina
ES404603A1 (es) Un procedimiento para la produccion de espectinomicina.
GB841420A (en) A method of producing citric acid by fermentation
ES8100809A3 (es) Procedimiento de obtencion de pregna 1,4 dienos
ES315944A1 (es) Procedimiento de produccion de alanosina.
BE797862A (en) Pepsinostreptin and pepsinostreptin-p and their methyl - esters - protease inhibitors used to treat ulcers, hyperpepsia, hyper
GB1230279A (pl)
ES452083A1 (es) Un procedimiento para la obtencion de nocardicina.
ES420358A1 (es) Un procedimiento para la preparacion de 3-monoesteres de rosamicina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19930212